You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Products Articles
Popular Products Articles
Highly Recommended Products Articles
Send a link to this page to your friends and colleagues.
Advanced Tissue Sciences Inc. of La Jolla, California, and Smith & Nephew PLC, of London, England, announced the FDA approval of Dermagraft, a treatment for foot ulcers resulting from diabetic neuropathy. Advanced Tissue Sciences is the first company in the United States to receive FDA approval for a skin treatment that is engineered from human cells.
Dermagraft is a skin substitute that contains active, living cells. It comes in the form of a thin sheet of human tissue that must be applied by a clinician. Once the foot wound is cleaned, the sheet of tissue is placed on the wound, measured to fit the area and cut from the sheet. Then, the tissue is implanted into the wound by a doctor.
For more information on Dermagraft, call Smith & Nephew's Wound Management Division at (800) 876-1261.
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.